Cite
HARVARD Citation
Gong, C. et al. (2022). Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data. Therapeutic advances in drug safety. p. . [Online].